Extremity Reconstruction Market Overview:
Extremity Reconstruction Market was valued at $1,833 million in 2015, and is expected to reach $3,041 million by 2022, supported by a CAGR of 7.5% during the forecast period 2016 to 2022. Extremity reconstruction devices are used to treat, repair, replace, or heal extremity injuries such as fractures or damage.
The extremity reconstruction market covers implant devices for the shoulder, elbow, wrist, digits, foot, and ankle joints. The market is segmented based on the product type into upper extremity reconstruction devices and lower extremity reconstruction devices. The extremity reconstruction segment holds a small share in the global orthopedic market but it is expected to grow at the fastest rate during the study period. Hence, the leading companies have increased their focus on the segment to overcome the sluggish growth in the hip and knee joint reconstruction market.
Extremity Reconstruction Market Segmentation
TOP INVESTMENT POCKETS
Shoulder reconstruction and ankle replacement are the potential target areas for investment by the key players in the extremity reconstruction market. Shoulder reconstruction is the highest revenue-generating segment in this market owing to rise in joint-related disorders, technological advancements such as reverse shoulder and stemless shoulder implants and large patient population. Recent developments in the market such as approval of stemless shoulder implant, Simpliciti by Wright Medical, in the U.S, increasing adoption rate of reverse shoulder implants and increasing use of natural biomaterial to improve the osseo-integration rate and the strength of bone-prosthetic bonding are expected to strengthen the market. Stemless shoulder replacement is ideal for patients with post-traumatic osteoarthritis of the shoulder and extra-articular deformities of the proximal humerus, which can make the placement of a conventional stemmed prosthesis difficult or impossible. For patients with massive irreparable rotator tear, who cannot opt for conventional total shoulder replacement, reverse shoulder replacement has emerged as a boon.
Top investment pockets
The ankle replacement segment is expected to exhibit momentous growth in the extremity reconstruction market due to increasing adoption rate in developed economies and restoration of range of movements of the ankles. In addition, technological advancements such as three-part mobile bearing un-cemented total ankle replacement devices, growing incidences of ankle arthritis and development of less invasive techniques are further expected to propel the market. With encouraging results of pipeline products and increasing number of regulatory approvals for the total ankle replacement devices, the future for the ankle replacement market seems bright.
TOP FACTORS IMPACTING GLOBAL EXTREMITY RECONSTRUCTION MARKET
Increasing incidences of joint disabling diseases, trauma and sports injuries
With improvements and advancements in healthcare facilities, there has been an increase in life expectancy across the globe. As estimated by Global Health and Ageing Report, WHO 27% of the Japanese, 16% of the American, 24% of the British, 17% of the Russian, and 14% of the Chinese population will be above 65 years of age by 2020. Due to aging, there is an increasing prevalence of joint disorders. According to the Centers of Disease Control and Prevention, with an increase in the aging population in the U.S., the number of patients suffering from arthritis is expected to increase to 78 million by the year 2040. The prevalence of osteoarthritis increases indefinitely with age, as the condition is irreversible. Cases of trauma and sports injury are also increasing. According to the National Center for Health Statistics, in 2011, 77% of all injury health care visits were for musculoskeletal injuries. Hence, the demand for extremity reconstruction devices is expected to increase globally.
Technological advancements in the field of extremity implants
Continuous technological innovations in the field of extremity implants and surgery, such as stemless shoulder implant, reverse shoulder implant, mobile bearing ankles, and new implant materials with better safety are set to drive the market for extremity implants. For instance, advancements in ankle joint replacement provide surgeons with more options when treating ankle arthritis and also increase the longevity of the implants. Recent success in total elbow arthroplasty with the development of devices such as Comprehensive Segmental Revision System from Zimmer Biomet has provided solutions for implant failures. Small startup companies are developing innovative technologies such as development of minimally invasive endoscopic techniques for extremity implants which has also reduced the recovery time and pain. For instance, Instratek launched HammerFIT Extremity Reamer System for hammertoe surgery.
Increasing awareness and patient preference to maintain an active lifestyle
The extremity reconstruction is the fastest growing segment of reconstructive joint replacement market. This is mainly due to increasing awareness and preference of patients to maintain an active lifestyle after joint disorders and trauma or injury. According to the Centers for Disease Control and Prevention, in 2012, there were 65,000 shoulder replacement procedures performed in the U.S. Furthermore, according to the National Institute of Health, there has been a 393% increase in the total shoulder arthroplasty procedures performed from 2001 to 2010 due to increasing awareness.
Obesity and diabetes epidemic increasing the risk of degenerative joint diseases
Aliments such as diabetes and obesity increase the risk of degenerative joint disease manifold. It is estimated that about 285 million people suffered from diabetes in 2010, and this is estimated to increase to 438 million by 2030 [Report Global Burden of Disease, WHO]. People with diabetes are at an increased risk of osteoporosis and joint disorders. Similarly, a person with obesity is around 60% more likely to develop arthritis and other joint disorders.
The key players profiled in the report include DePuy Synthes (a wholly owned subsidiary of Johnson & Johnson), Stryker Corporation, Zimmer Biomet Holdings, Inc., Smith & Nephew plc, Integra Lifesciences Holdings Corporation, Wright Medical Group N.V., Acumed, Inc., Arthrex, Inc., CONMED Corporation, and Skeletal Dynamics LLC.
Extremity Reconstruction Market Key Segments
The Global extremity reconstruction market is segmented based on product, applications, biomaterial and geography.
- Upper Extremity Reconstruction
- Partial Shoulder Replacement
- Total Standard Replacement
- Stemless Total Shoulder Replacement
- Total Reverse Replacement
- Hand & Wrist
- Lower Extremity Reconstruction
- Foot Devices
- Hind foot Fusion
- Other Fusions
- Ankle Reconstruction Devices
- Ankle Fusion
- Ankle Replacement
- Foot Devices
- Metallic Biomaterial
- Ceramic Biomaterial
- Polymeric Biomaterial
- Natural Biomaterial
- North America
- Rest of Europe
- South Korea
- Rest of Asia-Pacific
- South Africa
- Saudi Arabia